183 related articles for article (PubMed ID: 15786672)
1. Stroke prevention in atrial fibrillation: are we following the guidelines?
Pusser BE; Robertson SL; Robinson MD; Barton C; Dobson LA
N C Med J; 2005; 66(1):9-13. PubMed ID: 15786672
[TBL] [Abstract][Full Text] [Related]
2. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
3. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
4. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?
Putnam W; Nicol K; Anderson D; Brownell B; Chiasson M; Burge FI; Flowerdew G; Cox J
Can Fam Physician; 2004 Sep; 50():1244-50. PubMed ID: 15508374
[TBL] [Abstract][Full Text] [Related]
7. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
8. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
9. The use of warfarin in veterans with atrial fibrillation.
Bravata DM; Rosenbeck K; Kancir S; Brass LM
BMC Cardiovasc Disord; 2004 Oct; 4(1):18. PubMed ID: 15498102
[TBL] [Abstract][Full Text] [Related]
10. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
11. Community-based study of atrial fibrillation and stroke prevention.
White S; Feely J; O'Neill D
Ir Med J; 2004 Jan; 97(1):10-2. PubMed ID: 15055913
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.
Laguna P; Martn A; del Arco C; Gargantilla P;
Ann Emerg Med; 2004 Jul; 44(1):3-11. PubMed ID: 15226703
[TBL] [Abstract][Full Text] [Related]
13. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
Burkiewicz JS
Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096
[TBL] [Abstract][Full Text] [Related]
14. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
[TBL] [Abstract][Full Text] [Related]
15. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
Garwood CL; Corbett TL
Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
[TBL] [Abstract][Full Text] [Related]
16. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.
Waldo AL; Becker RC; Tapson VF; Colgan KJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1729-36. PubMed ID: 16256877
[TBL] [Abstract][Full Text] [Related]
17. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?
Zimetbaum PJ; Thosani A; Yu HT; Xiong Y; Lin J; Kothawala P; Emons M
Am J Med; 2010 May; 123(5):446-53. PubMed ID: 20399322
[TBL] [Abstract][Full Text] [Related]
18. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in atrial fibrillation: an assessment of compliance with guidelines.
Nair A; Hazell W; Sutton T; Pillai S
N Z Med J; 2005 Jan; 118(1208):U1258. PubMed ID: 15682210
[TBL] [Abstract][Full Text] [Related]
20. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
Peterson GM; Boom K; Jackson SL; Vial JH
Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
